Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000447 |
Aldehydes |
SLC11A2 protein inhibits the reaction [Ozone results in increased abundance of Aldehydes] | decreases reaction|increases abundance | 16905637
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC11A2 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic affects the expression of SLC11A2 mRNA | affects expression | 18414638
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of SLC11A2 mRNA | increases expression | 16272461
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of SLC11A2 protein | increases expression | 16272461
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of SLC11A2 mRNA | decreases expression | 20106945
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of SLC11A2 mRNA | increases expression | 15336504
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of SLC11A2 mRNA | decreases expression | 14729362
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in decreased expression of SLC11A2 mRNA | decreases expression | 17720352
|
D002104 |
Cadmium |
SLC11A2 protein affects the transport of Cadmium | affects transport | 16552559
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SLC11A2 mRNA | decreases expression | 20106945
|
D013759 |
Tetrahydrocannabinol |
Tetrahydrocannabinol inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] | decreases reaction|increases uptake | 16984886
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of SLC11A2 mRNA | decreases expression | 19061943
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of SLC11A2 protein | decreases expression | 19061943
|
D004052 |
Diethylnitrosamine |
Iron inhibits the reaction [Diethylnitrosamine results in decreased expression of SLC11A2 protein] | decreases expression|decreases reaction | 19061943
|
C042986 |
ebselen |
ebselen inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] | decreases reaction|increases uptake | 16984886
|
D004958 |
Estradiol |
Estradiol affects the expression of SLC11A2 mRNA | affects expression | 16684588
|
D000431 |
Ethanol |
Ethanol results in increased expression of SLC11A2 protein | increases expression | 16737972
|
D000431 |
Ethanol |
HAMP protein inhibits the reaction [Ethanol results in increased expression of SLC11A2 protein] | decreases reaction|increases expression | 16737972
|
D000431 |
Ethanol |
Vitamin E inhibits the reaction [Ethanol results in increased expression of SLC11A2 protein] | decreases reaction|increases expression | 16737972
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SLC11A2 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SLC11A2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC11A2 mRNA | affects cotreatment|increases expression | 17942748
|
C013531 |
ferric ammonium citrate |
ferric ammonium citrate results in increased expression of SLC11A2 mRNA | increases expression | 11054110
|
C020326 |
ferric nitrilotriacetate |
ferric nitrilotriacetate results in decreased expression of SLC11A2 mRNA | decreases expression | 11925462
|
D007501 |
Iron |
ebselen inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] | decreases reaction|increases uptake | 16984886
|
D007501 |
Iron |
[HFE protein binds to B2M protein binds to SLC11A2 protein] which results in decreased uptake of Iron | affects binding|decreases uptake | 16841247
|
D007501 |
Iron |
prolinedithiocarbamate inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] | decreases reaction|increases uptake | 16984886
|
D007501 |
Iron |
Tetrahydrocannabinol inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] | decreases reaction|increases uptake | 16984886
|
D007501 |
Iron |
Iron inhibits the reaction [Diethylnitrosamine results in decreased expression of SLC11A2 protein] | decreases expression|decreases reaction | 19061943
|
D007501 |
Iron |
Iron results in increased expression of SLC11A2 mRNA | increases expression | 16648237
|
D007501 |
Iron |
SLC11A2 gene mutant form results in decreased transport of Iron | decreases transport | 17116712
|
D007501 |
Iron |
SLC11A2 protein affects the metabolism of Iron | affects metabolic processing | 17194590
|
D007501 |
Iron |
Iron inhibits the reaction [SLC11A2 protein results in increased uptake of Manganese] | decreases reaction|increases uptake | 17116743
|
D007501 |
Iron |
Iron inhibits the reaction [SLC11A2 protein results in increased uptake of manganese chloride] | decreases reaction|increases uptake | 17116743
|
D007501 |
Iron |
Iron results in decreased expression of SLC11A2 protein | decreases expression | 17116743
|
D007501 |
Iron |
Iron results in increased expression of SLC11A2 mRNA | increases expression | 15908475
|
D007501 |
Iron |
Iron results in increased expression of SLC11A2 protein | increases expression | 15908475
|
D007501 |
Iron |
Metals promotes the reaction [SLC11A2 protein results in increased transport of Iron] | increases reaction|increases transport | 15908475
|
D007501 |
Iron |
Nitric Oxide promotes the reaction [[RASD1 protein binds to ACBD3 protein binds to SLC11A2 protein] which results in increased uptake of Iron] | affects binding|increases reaction|increases uptake | 16908409
|
D007501 |
Iron |
SLC11A2 gene mutant form results in decreased uptake of Iron | decreases uptake | 17116712
|
D007501 |
Iron |
SLC11A2 protein affects the metabolism of Iron | affects metabolic processing | 17194590
|
D007501 |
Iron |
SLC11A2 protein mutant form results in decreased uptake of Iron | decreases uptake | 17116743
|
D019266 |
Iron, Dietary |
Iron, Dietary affects the expression of SLC11A2 mRNA | affects expression | 15637178
|
D007608 |
Kainic Acid |
Kainic Acid results in increased expression of SLC11A2 | increases expression | 16552559
|
D007854 |
Lead |
SLC11A2 protein affects the transport of Lead | affects transport | 16552559
|
D001556 |
Lindane |
Lindane results in increased expression of SLC11A2 mRNA | increases expression | 17785943
|
D008070 |
Lipopolysaccharides |
IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of SLC11A2 mRNA] | increases expression|increases reaction | 11054110
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of SLC11A2 mRNA | increases expression | 16648237 11054110
|
D008345 |
Manganese |
Manganese results in increased expression of SLC11A2 mRNA | increases expression | 17175027
|
D008345 |
Manganese |
Iron inhibits the reaction [SLC11A2 protein results in increased uptake of Manganese] | decreases reaction|increases uptake | 17116743
|
D008345 |
Manganese |
Manganese results in increased expression of SLC11A2 mRNA | increases expression | 16729984
|
D008345 |
Manganese |
Manganese results in increased expression of SLC11A2 protein | increases expression | 16729984 16705042
|
D008345 |
Manganese |
Manganese results in increased stability of [ACO1 protein binds to SLC11A2 mRNA] | affects binding|increases stability | 16729984
|
D008345 |
Manganese |
SLC11A2 protein mutant form results in decreased metabolism of Manganese | decreases metabolic processing | 17116743
|
D008345 |
Manganese |
SLC11A2 protein mutant form results in decreased uptake of Manganese | decreases uptake | 17116743
|
C025340 |
manganese chloride |
manganese chloride results in increased expression of SLC11A2 mRNA | increases expression | 17175027
|
C025340 |
manganese chloride |
Iron inhibits the reaction [SLC11A2 protein results in increased uptake of manganese chloride] | decreases reaction|increases uptake | 17116743
|
C025340 |
manganese chloride |
SLC11A2 protein mutant form results in decreased uptake of manganese chloride | decreases uptake | 17116743
|
D008670 |
Metals |
Metals inhibits the reaction [SLC11A2 protein results in increased transport of Vanadium] | decreases reaction|increases transport | 15908475
|
D008670 |
Metals |
Metals promotes the reaction [SLC11A2 protein results in increased transport of Iron] | increases reaction|increases transport | 15908475
|
D008670 |
Metals |
SLC11A2 protein results in increased transport of Metals | increases transport | 15908475
|
D009569 |
Nitric Oxide |
Nitric Oxide affects the expression of SLC11A2 protein alternative form | affects expression | 16232120
|
D009569 |
Nitric Oxide |
Nitric Oxide promotes the reaction [[RASD1 protein binds to ACBD3 protein binds to SLC11A2 protein] which results in increased uptake of Iron] | affects binding|increases reaction|increases uptake | 16908409
|
D010126 |
Ozone |
SLC11A2 protein inhibits the reaction [Ozone results in increased abundance of Aldehydes] | decreases reaction|increases abundance | 16905637
|
D010126 |
Ozone |
SLC11A2 protein inhibits the reaction [Ozone results in increased secretion of IL8 protein] | decreases reaction|increases secretion | 16905637
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased methylation of SLC11A2 promoter | decreases methylation | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of SLC11A2 mRNA | increases expression | 19482888
|
C066229 |
prolinedithiocarbamate |
prolinedithiocarbamate inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] | decreases reaction|increases uptake | 16984886
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of SLC11A2 mRNA | affects cotreatment|decreases expression | 19244175
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of SLC11A2 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC11A2 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLC11A2 mRNA | decreases expression | 19465110
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SLC11A2 mRNA | increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin affects the expression of SLC11A2 mRNA alternative form | affects expression | 16232120
|
D014212 |
Tretinoin |
Tretinoin affects the expression of SLC11A2 protein alternative form | affects expression | 16232120
|
D014212 |
Tretinoin |
Tretinoin affects the reaction [RELA protein binds to SLC11A2 promoter] | affects binding|affects reaction | 16232120
|
D014639 |
Vanadium |
Metals inhibits the reaction [SLC11A2 protein results in increased transport of Vanadium] | decreases reaction|increases transport | 15908475
|
D014639 |
Vanadium |
Vanadium results in decreased expression of SLC11A2 mRNA | decreases expression | 15908475
|
D014639 |
Vanadium |
Vanadium results in decreased expression of SLC11A2 protein | decreases expression | 15908475
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of SLC11A2 mRNA | affects cotreatment|decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of SLC11A2 mRNA | decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E inhibits the reaction [Ethanol results in increased expression of SLC11A2 protein] | decreases reaction|increases expression | 16737972
|
D015032 |
Zinc |
Zinc results in increased expression of SLC11A2 mRNA | increases expression | 16614402
|
D015032 |
Zinc |
Zinc results in increased expression of SLC11A2 protein | increases expression | 16614402
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.16 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
12.05 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
12.05 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
12.05 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.20 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.20 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.55 | 17505938 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.02 | 16889938 17202136 17190629 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.68 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.36 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.36 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.36 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
5.88 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
5.88 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
15.13 | 16434500 19061943 17162532 19052882 18056438 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
15.13 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.13 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
4.82 | 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
4.00 | 12661182 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.93 | 15451040 15451039 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.32 | 15955085 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.27 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
8.73 | 16640825 16563566 |
MESH:D000544 |
Alzheimer Disease |
|
Nitric Oxide |
8.73 | 17556102 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
8.73 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
8.73 | 16325427 16580781 17119284 16410023 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Tetrahydrocannabinol |
4.59 | 15204022 |
MESH:D000740 |
Anemia |
|
Iron |
7.83 | 16434484 16566752 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.83 | 11748828 |
OMIM:206100 |
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD |
marker/mechanism |
|
| |
MESH:D018798 |
Anemia, Iron-Deficiency |
marker/mechanism |
|
| 17116712 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.32 | 17162259 17163184 16569441 17375513 17147795 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.54 | 16916123 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
15.93 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
15.93 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
15.93 | 16910769 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.45 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.71 | 11141031 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.70 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
4.04 | 16604332 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.75 | 16835338 16251483 12569548 18414634 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.09 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.41 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.41 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.33 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.33 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
7.23 | 16373670 17854713 |
MESH:D001249 |
Asthma |
|
Tretinoin |
7.23 | 16456186 |
MESH:D001249 |
Asthma |
|
Zinc |
7.23 | 17085522 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
5.07 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
13.90 | 19371607 12928151 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
13.90 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
13.90 | 16640825 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Tetrahydrocannabinol |
13.90 | 15815632 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.83 | 17352947 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.81 | 16640825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.04 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.81 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
7.81 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.52 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.32 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.53 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
6.53 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
6.53 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.53 | 18497071 12948864 19861407 17018787 14630087 16675129 17261762 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
6.53 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
Nitric Oxide |
6.53 | 15631943 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
6.53 | 19084267 21152245 18855134 19289846 16202921 19200415 19103187 19288272 19155303 20065188 11161223 19487384 20135344 21138602 19059307 20859285 19244106 18815881 18351453 17440819 19142967 19011961 18629630 17893378 19189210 19410462 19189212 20544844 16273361 16873071 18425577 19066611 17049068 18984771 20005174 19221464 16818667 15565566 20390343 19115204 17242785 18821012 15668708 18997820 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.53 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.53 | 16443354 16166294 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Vanadium |
6.53 | 15565634 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.38 | 19059883 15516495 14754758 16777450 18315731 17626835 18417511 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.21 | 16813970 |
MESH:D002056 |
Burns |
|
Ethanol |
4.28 | 16374292 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.36 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.08 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.56 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.50 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.37 | 17687452 15504454 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.13 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.77 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
15.66 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
15.66 | 11831363 16502159 16779866 10737359 19701751 16328049 20084675 18210153 16698587 19052882 16807293 19383236 18978308 16540662 18785209 18506893 20007298 18665156 19822196 18788625 20935162 17978847 18393292 10672840 20524982 20727157 17428255 16569478 3581430 20514400 19539802 18056438 19519916 18691550 19335982 3084413 21159647 19919837 19394651 16288022 17173139 16878318 16830150 16681979 17761372 20214788 17162532 19208518 20512989 18971187 17055752 20101231 20432363 18494052 19107877 16935385 17138121 19418558 19171122 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.66 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
15.66 | 15763234 18788625 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
15.66 | 6705139 17173139 20007298 1701930 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
15.66 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
15.66 | 1917145 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vanadium |
15.66 | 16830150 16878318 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
ferric nitrilotriacetate |
4.19 | 8340253 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
9.80 | 15504454 17687452 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
9.80 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
9.80 | 16096774 16051514 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
9.80 | 16543248 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
8.41 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.41 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.13 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.13 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
3.79 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
3.32 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
6.76 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
6.76 | 16936243 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.99 | 18022660 16973168 |
MESH:D002375 |
Catalepsy |
|
Tetrahydrocannabinol |
5.34 | 10318961 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.87 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
18.34 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
18.34 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
18.34 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
18.34 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Vanadium |
18.34 | 17174075 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.88 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.21 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.26 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
11.93 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
11.93 | 17333356 16105132 16919318 17681005 11677210 17110522 15861022 |
MESH:D002779 |
Cholestasis |
|
Nitric Oxide |
11.93 | 16919318 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.77 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.38 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
8.86 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
8.86 | 8697196 12621046 15340226 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
8.86 | 9407595 |
MESH:D003092 |
Colitis |
|
Selenium |
8.26 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
8.26 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
4.35 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
Vanadium |
4.35 | 18155637 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.74 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
8.83 | 15513904 10194807 15451039 11873399 15451040 19302082 11198716 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Lead |
8.83 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
8.83 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
8.83 | 9142499 9664655 9224671 9125849 9211117 16925845 8800419 17551590 10589399 14991402 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
8.83 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
8.83 | 19302082 |
MESH:D003704 |
Dementia |
|
Lead |
4.91 | 16140633 |
MESH:D015140 |
Dementia, Vascular |
|
Nitric Oxide |
5.58 | 17556102 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.99 | 19031437 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
8.58 | 16640825 16604332 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
8.58 | 16479319 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.23 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.56 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
6.56 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.56 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.78 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.78 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
7.96 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
7.96 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
7.96 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
7.96 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.48 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.65 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.32 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.05 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.65 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.65 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.75 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.75 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
10.97 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
10.97 | 16202921 17893378 19155303 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
10.97 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.69 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.02 | 17637181 15821434 15328337 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.74 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.49 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.56 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Tetrahydrocannabinol |
6.56 | 821787 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.23 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.88 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.64 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.73 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.73 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
6.73 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
6.73 | 16543248 |
MESH:D020329 |
Essential Tremor |
|
Lead |
5.55 | 14594619 18007985 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.90 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.90 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
26.31 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
26.31 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
26.31 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
26.31 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
26.31 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
26.31 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.28 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.00 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.92 | 15451040 10194807 15513904 16946407 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.08 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
Lead |
5.18 | 19769572 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.69 | 9205823 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.15 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.80 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
12.57 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.57 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.57 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.17 | 6392382 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
5.05 | 16604332 16640825 |
MESH:D005756 |
Gastritis |
|
Ethanol |
10.25 | 15046732 |
MESH:D005756 |
Gastritis |
|
Zinc |
10.25 | 17241300 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.84 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
6.62 | 17043766 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.62 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.21 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.72 | 17217573 |
MESH:D006261 |
Headache |
|
Nitric Oxide |
4.79 | 11554966 11284996 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.93 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.77 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
14.26 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
14.26 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
14.26 | 9664655 14991402 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
14.26 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.55 | 17162251 |
MESH:D006333 |
Heart Failure |
|
Zinc |
6.55 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.38 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.18 | 17241300 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.21 | 17255318 16640825 16604332 16574947 17236123 17053826 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.04 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.05 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.00 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.83 | 16604332 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
5.08 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
10.06 | 17182432 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
10.06 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
12.41 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
12.41 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.41 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.56 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.64 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.47 | 16597321 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
8.76 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
8.76 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.66 | 16354765 16959395 15340226 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
7.01 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.01 | 16870215 |
MESH:D006940 |
Hyperemia |
|
Nitric Oxide |
5.23 | 11156591 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.20 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.13 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
7.68 | 11953799 16076760 9931084 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.68 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.68 | 18850075 18670907 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Nitric Oxide |
4.15 | 15838368 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.17 | 16093927 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.13 | 16640825 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.44 | 16569931 16945680 |
MESH:D007035 |
Hypothermia |
|
Tetrahydrocannabinol |
5.55 | 10318961 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.71 | 16640825 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.11 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.31 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Lead |
6.31 | 16780224 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
13.72 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
13.72 | 17255318 12878042 17963957 9205823 17237260 |
MESH:D007249 |
Inflammation |
|
Metals |
13.72 | 16786165 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
13.72 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
13.72 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
9.67 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
9.67 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.72 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Nitric Oxide |
8.87 | 10210152 11713966 11574821 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
8.87 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
10.42 | 17163184 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
10.42 | 17255318 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.26 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
15.21 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
15.21 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
15.21 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.05 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.61 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
20.97 | 16962696 16226777 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
20.97 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
20.97 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
ferric nitrilotriacetate |
20.97 | 15834431 18617210 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
20.97 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
20.97 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
8.95 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
8.95 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
15.30 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
15.30 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
ferric nitrilotriacetate |
15.30 | 18055543 9667754 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
15.30 | 18625569 |
MESH:D007855 |
Lead Poisoning |
|
Lead |
5.55 | 16700817 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
8.96 | 15451040 |
MESH:D007859 |
Learning Disorders |
|
Lead |
8.96 | 16384672 |
MESH:D007896 |
Leishmaniasis |
|
Nitric Oxide |
4.34 | 17218153 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.58 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.36 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.01 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
6.92 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.92 | 19035177 17294898 17368321 12679006 16766008 16935935 16788101 17649720 17107899 17217047 19642359 19225113 9834237 17361223 17339181 17506722 19075265 16140955 17712046 16823087 15748426 19029980 16331271 17301526 16891316 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.32 | 15821434 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
5.05 | 16563566 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
7.41 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.41 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.88 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
14.05 | 18665156 19638242 18522880 18407596 20032147 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
14.05 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
14.05 | 16640825 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
14.05 | 21047994 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.71 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.06 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
10.06 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
10.06 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
10.06 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.06 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
10.06 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
10.06 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
8.54 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
8.54 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
8.54 | 1715830 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
8.54 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
10.25 | 17207112 17347304 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
10.25 | 17207112 16737972 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
19.51 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
19.51 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
19.51 | 19426721 19255062 2862719 20101389 16942905 19638242 19427195 15885732 19833225 21278145 19690152 19294768 19073162 18754104 21047994 19996281 19256749 18977376 20492335 19551842 19642983 20118626 9163691 12112319 21071580 2422723 21167192 20434301 10737359 20501860 20405173 18644402 19812893 12771043 20137499 19090486 19254457 20452335 15175105 19850985 18648771 20583210 19499222 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
19.51 | 20302851 16640825 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
19.51 | 19073162 8742319 21047994 19812893 15975961 19482888 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
19.51 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
19.51 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
12.21 | 18308698 21159647 3124819 19009564 16842330 16267830 18093689 17174075 18164116 19004024 18253720 17854601 9362446 18775883 17942915 18544905 19126423 18079962 19539802 18282651 19519916 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
12.21 | 18308698 1399818 17172636 6150874 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.21 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vanadium |
12.21 | 17174075 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
6.66 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
6.66 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
18.59 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
18.59 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Nitric Oxide |
18.59 | 11395602 |
MESH:D055370 |
Lung Injury |
|
Ozone |
18.59 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
12.01 | 19168569 17976673 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
12.01 | 20064080 20464547 20869020 18520028 18569708 17053015 18816296 6695378 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
12.01 | 20970405 21163286 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
12.01 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
12.01 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
12.01 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.01 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
12.01 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Nitric Oxide |
4.01 | 16166326 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.77 | 16640825 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.38 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.25 | 11408345 17203775 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
12.25 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
12.25 | 14580682 16827153 19196723 11731420 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
12.25 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
20.14 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
20.14 | 16568477 19453300 16551646 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
20.14 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.63 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.05 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.05 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.80 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
8.92 | 18411066 15451040 |
MESH:D008569 |
Memory Disorders |
|
Lead |
8.92 | 16384672 17263510 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.05 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
5.80 | 18303189 16966607 16166281 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
5.80 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.40 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.72 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Nitric Oxide |
4.01 | 11701602 |
MESH:D020326 |
Migraine without Aura |
|
Nitric Oxide |
4.75 | 14659530 11304026 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.90 | 16381670 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.66 | 16551646 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.28 | 17086897 |
MESH:D009181 |
Mycoses |
|
Iron |
5.08 | 16640825 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.86 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
13.62 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
13.62 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
13.62 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.77 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
7.77 | 16604332 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.09 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.19 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.19 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.39 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.24 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Lindane |
7.24 | 12807735 16818664 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.24 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.61 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.35 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.42 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
8.42 | 17178036 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
3.99 | 16551646 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.24 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.24 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.24 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
10.95 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tetrahydrocannabinol |
10.95 | 19040278 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
10.95 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.66 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
7.66 | 17296847 16604332 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.02 | 17056641 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.73 | 20387270 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.73 | 16640825 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.98 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Iron |
3.62 | 16640825 16648989 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
7.15 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.15 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.15 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.61 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.13 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
11.13 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
11.13 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.13 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.34 | 11578682 |
MESH:D010212 |
Papilloma |
|
Iron |
4.11 | 12065085 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.63 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
5.41 | 16640825 16563566 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
5.41 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.14 | 16140633 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.86 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.82 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
11.82 | 15371236 16905509 6392382 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
11.82 | 15687053 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.76 | 16369182 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.28 | 16604332 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.50 | 15087411 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.52 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
9.83 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
9.83 | 18381685 18929643 18007984 |
MESH:D011015 |
Pneumonia, Aspiration |
|
Nitric Oxide |
4.95 | 18573544 |
MESH:D011041 |
Poisoning |
|
Iron |
3.94 | 16604332 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
9.82 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
9.82 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
13.43 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
13.43 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
13.43 | 2563599 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
8.57 | 16640825 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
8.57 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Lead |
8.72 | 16384672 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.72 | 11896295 11222880 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.54 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.35 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.35 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.35 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.35 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
2.35 | 14688026 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.35 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.35 | 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
2.35 | 16517595 16606632 12429649 16700911 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
8.11 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
8.11 | 16636307 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.63 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.93 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.11 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.09 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.41 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.88 | 17975199 15814490 17322281 17365031 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.48 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.47 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.26 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
3.84 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.75 | 16116481 16283617 |
MESH:D012555 |
Schistosomiasis mansoni |
|
Nitric Oxide |
5.08 | 9673227 |
MESH:D012640 |
Seizures |
|
Ethanol |
12.10 | 9754883 |
MESH:D012640 |
Seizures |
|
Kainic Acid |
12.10 | 18657176 1641125 19414003 16336964 14637104 17827730 15686955 10686065 19186208 |
MESH:D012640 |
Seizures |
|
Lindane |
12.10 | 15475178 12842176 7539098 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
12.10 | 3137016 16876388 4039156 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.44 | 6407741 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
4.67 | 18709164 15952646 16759981 16353154 19834688 17938729 16702368 17548696 6392382 17453740 17050553 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
4.67 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
20.04 | 17976673 15504454 17050553 19538983 17029826 16251483 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
20.04 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
20.04 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
20.04 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
20.04 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
20.04 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Kainic Acid |
5.32 | 19414003 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.27 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.27 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.66 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.36 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.36 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
4.36 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.36 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
6.70 | 9211565 11906479 16755016 9562338 17918041 17189318 |
MESH:D013276 |
Stomach Ulcer |
|
Nitric Oxide |
6.70 | 15138204 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.22 | 16517955 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.93 | 9754883 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
5.07 | 16640825 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.84 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.27 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.83 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.51 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
10.30 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
10.30 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
10.30 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.30 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.88 | 16051514 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
8.88 | 16543248 |
MESH:D014202 |
Tremor |
|
Lead |
5.10 | 21145352 |
MESH:D014376 |
Tuberculosis |
|
Iron |
7.38 | 16597321 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
7.38 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
10.68 | 19429237 17976673 18640142 17306315 15987713 19322015 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
10.68 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
10.68 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
10.68 | 8653321 17572228 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.35 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.94 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.22 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.60 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.35 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.21 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.20 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.69 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.86 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.65 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.05 | 17120751 |